Inositol Market Size, Share & Industry Analysis, By Source (Plant-based and Animal-based), By Application (Dietary Supplements, Beverages, Animal Feed, Pharmaceutical Industry, and Others) and Regional Forecast, 2024-2032

Inositol, also called myo-inositol, hexaphosphate (IP6) or D-chiro-inositol. The product is a naturally occurring nutrient found in plants and animals. Inositol plays an essential role in many bodily functions, including cell signaling, hormone regulation, and mood control. An increasing number of consumers are affected by diseases such as diabetes and PCOS owing to the adoption of a poor lifestyle and the rise in consumption of junk food. This has led to a rise in demand for supplements and drugs containing Inositol owing to its curing properties, and it is known to be a member of the vitamin B complex. According to the IDF Diabetes Atlas, in 2021, 537 million adults across the globe lived with diabetes, and the number is predicted to rise to 643 million by 2030.

The growing trend toward natural and organic products extends to supplements as well. Inositol being a naturally occurring nutrient, aligns with this consumer preference for natural remedies. Manufacturers are also responding to this trend by launching innovative products in order to meet the rising demand. For instance, in August 2023, BioSyent Inc., a specialty pharmaceutical company, commenced the first shipments of Inofolic in the Canadian marketplace. The new product is a natural health product that combines myo-inositol and folic acid in a unique soft-gel capsule for women living with PCOS. 

Key Insights

The report covers the following key insights:

• Overview of the Inositol Market


• Supply Chain and Regulatory Analysis


• Drivers, Restraints, and Opportunities


• Impact of COVID-19 on the Global Inositol Market


• Key Developments

Segmentation

Analysis by Source

Based on the source, the market is bifurcated into plant-based and animal-based. The animal-based segment is expected to hold a major share of the global market. Extracting Inositol from animal sources, such as whey is a more established and cost-efficient process compared to plant-based methods. This translates to lower production costs and potentially more affordable inositol supplements to consumers. Moreover, the infrastructure for obtaining and processing animal-based Inositol is already well-developed, allowing manufacturers to source and produce Inositol from ready sources and produce Inositol from animal-based sources.

The plant-based source is expected to grow significantly over the forecast period. The increasing number of people following vegan and vegetarian diets would create a demand for plant-based inositol alternatives.

Analysis by Application

By application, the market is segmented into dietary supplements, beverages, animal feed, pharmaceutical industry, and others. The pharmaceutical segment holds the largest share of the global Inositol market. Inositol, particularly Myo-inositol, helps effectively results in regulating menstrual cycles and improve insulin sensitivity in women with PCOS. Studies have also suggested that Inositol plays a significant role in mood regulation and could be beneficial for managing anxiety and depression. Insoitols’s potential to improve nerve pain associated with diabetes is being explored, offering opportunities for diabetic neuropathy relief.

The application of inositol in dietary supplements is also expected to grow at a high CAGR over the forecast period. Research is ongoing, and some studies suggest that inositol combined with other supplements might help with hair loss, depression, and other health issues, especially in women. Such rising prevalences may increase the demand for supplements and fuel the market growth.

The application of inositol in the cosmetic industry is also expected to have high growth in the coming years. Inositol acts as a humectant, attracting and retaining moisture in the skin, making it a valuable ingredient for hydrating creams, lotions, and other cosmetic products.

Regional  Analysis

To gain extensive insights into the market, Request for Customization

The global market is geographically segmented into North America, Europe, Asia Pacific, South America, and the Middle East and Africa.

North America holds the largest share of the inositol market. The rising prevalence of PCOS, digestive disorders, and lifestyle-related health issues owing to the high consumption of processed foods and poor eating habits is expected to fuel the demand for inositol supplements in the region. North America is expected to witness significant growth owing to increasing government spending and the growing pharmaceutical sector. Manufacturers are also innovative products to meet the growing supplement demand. For instance, in March 2023, MD Logic Health, one of the leading providers of U.S.-made professional-grade nutraceuticals and physicians, collaborated with Cynthia Thurlow NP, an intermittent fasting and nutrition expert, in order to launch Inositol. The product was chosen for this collaboration due to the clinical data and mounting body of evidence supporting beneficial effects on metabolic flexibility, sleep enhancement, and brain function.

Over the past few years, Europeans are increasingly interested in natural health solutions and inositol’s potential to address various health concerns is gaining recognition. Moreover, the region has a well-established regulatory framework for dietary supplements, ensuring consumer confidence in inositol products potentially influencing market growth. Moreover, the growing government initiatives promoting healthy lifestyles and preventive healthcare could also indirectly support the inositol market growth.

Key Players Covered

The report includes the profiles of the following key players: Biological Engineering Technology Co.Ltd, Phoenix Herb Company, Holland And Barrett, Shandong Runde Biotechnology Co.Ltd, Ronas Chemicals Ind. Co. Ltd, Zhucheng Haotian Pharm Co. Ltd., Mr. Bill’s Pipe And Tobacco Company, T. J. Clark And Company, Changzhou Zhonglian Inositol Co. Ltd, and Charles Bowman And Company.

Key Industry Developments

• In September 2023, Inner Mongolia Kingdomway Pharmaceutical Co., Ltd., a wholly-owned subsidiary of Xiamen Kingdomway Group Company, announced the production of inositol and allulose. The project was accepted and publicized by the Hohhot Municipal Ecology and Environment Bureau.


• In January 2023, Anhui Huaheng Biotechnology Co., Ltd, a China-based company specializing in the research and development, production, and sales of amino acids, announced the launch of a new production of Inositol.


• In July 2022, Nature Sure, a Delhi-based pharmaceutical company, launched chewable health gummies. The new product contains potent ingredients such as inositol, zeaxanthin, astaxanthin, lutein, folic acid, and others.